Efficacy and tolerability of 17 alpha-hydroxyprogesterone caproate for the prevention of recurrent preterm labour.
Phase of Trial: Phase III
Latest Information Update: 04 Feb 2011
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Pregnancy; Preterm labour
- Focus Registrational; Therapeutic Use
- 04 Feb 2011 The approval of Makena [hydroxyprogesterone caproate injection; Hologic] was based on the results of this study, according to a KV Pharmaceutical Company media release.
- 05 Nov 2010 New trial record.